Forthcoming obligations for pharma companies to the the costs of extra wastewater treatment could mean higher drug prices, warns Lif, the Danish pharmaceutical industry association. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
